Atelerix Life Sciences
UEI: TD8NL4UWNVW8
• CAGE: 8ZNE9
Overview
Awardee Type
Parent
Company Description
Atelerix Life Sciences is developing ATLX-0199, an active thiol-based compound from our platform of novel drugs, reverses opioid-induced side effects such as OIRD.
Name
Atelerix Life Sciences
Headquarters
Charlottesville, VA
United States
United States
Most Recent Award
Sept. 14, 2023
Calculating
Federal contract and grant recipient
ATELERIX LIFE SCIENCES INC
(UEI TD8NL4UWNVW8, CAGE 8ZNE9)
is headquartered in Charlottesville VA.
The corporation
was founded in November 2020 and
federally registered in
April 2021.
Federal Award Analysis
Atelerix Life Sciences federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
ATELERIX LIFE SCIENCES INC
Division Name
ATELERIX LIFE SCIENCES INC.
Division Number
ATELERIX L
UEI
TD8NL4UWNVW8
CAGE Code
8ZNE9
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
Nov. 23, 2020
Initial Registration
April 19, 2021
Last Registration
Dec. 16, 2025
Registration Activation
Dec. 18, 2024
Registration Expiration
Dec. 16, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No